Mezzion Pharma Co.,Ltd. 140410.KQ Stock
Mezzion Pharma Co.,Ltd. Price Chart
Mezzion Pharma Co.,Ltd. 140410.KQ Financial and Trading Overview
Mezzion Pharma Co.,Ltd. stock price | 38850 KRW |
Previous Close | 26600 KRW |
Open | 27000 KRW |
Bid | 28450 KRW x 0 |
Ask | 28550 KRW x 0 |
Day's Range | 26800 - 28700 KRW |
52 Week Range | 12250 - 29350 KRW |
Volume | 597.56K KRW |
Avg. Volume | 565.72K KRW |
Market Cap | 242.72B KRW |
Beta (5Y Monthly) | 0.759764 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
140410.KQ Valuation Measures
Enterprise Value | 395.01B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 8.032391 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 13.073 |
Enterprise Value/EBITDA | -20.439 |
Trading Information
Mezzion Pharma Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.759764 |
52-Week Change | 60.72% |
S&P500 52-Week Change | 20.43% |
52 Week High | 29350 KRW |
52 Week Low | 12250 KRW |
50-Day Moving Average | 23576 KRW |
200-Day Moving Average | 16747.75 KRW |
140410.KQ Share Statistics
Avg. Volume (3 month) | 565.72K KRW |
Avg. Daily Volume (10-Days) | 277.16K KRW |
Shares Outstanding | 8.55M |
Float | 20.83M |
Short Ratio | N/A |
% Held by Insiders | 21.84% |
% Held by Institutions | 3.72% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | -81.66% |
Operating Margin (ttm) | -69.31% |
Gross Margin | 6.72% |
EBITDA Margin | -63.95% |
Management Effectiveness
Return on Assets (ttm) | -20.28% |
Return on Equity (ttm) | -60.64% |
Income Statement
Revenue (ttm) | 30.22B KRW |
Revenue Per Share (ttm) | 1130.99 KRW |
Quarterly Revenue Growth (yoy) | 13.60% |
Gross Profit (ttm) | 3.7B KRW |
EBITDA | -19326613504 KRW |
Net Income Avi to Common (ttm) | -24676575232 KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 37.58B KRW |
Total Cash Per Share (mrq) | 1405.39 KRW |
Total Debt (mrq) | 4.46B KRW |
Total Debt/Equity (mrq) | 13.1 KRW |
Current Ratio (mrq) | 2.149 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | -13509718016 KRW |
Levered Free Cash Flow (ttm) | -8099822080 KRW |
Profile of Mezzion Pharma Co.,Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | C&H Building |
ZIP | N/A |
Phone | 82 2 560 8000 |
Website | https://www.mezzion.co.kr |
Industry | |
Sector(s) | |
Full Time Employees | 44 |
Mezzion Pharma Co.,Ltd. engages in the development, licensing, and commercialization of drugs for the treatment of vascular diseases. It is developing Udenafil, a PDE5 inhibitor to treat erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension, overactive bladder, hepatic portal hypertension, and chronic obstructive pulmonary diseases. The company was formerly known as Dong-A Pharmtech Co., Ltd. and changed its name to Mezzion Pharma Co.,Ltd. in April 2013. Mezzion Pharma Co.,Ltd. was founded in 2002 and is based in Seoul, South Korea.
Q&A For Mezzion Pharma Co.,Ltd. Stock
What is a current 140410.KQ stock price?
Mezzion Pharma Co.,Ltd. 140410.KQ stock price today per share is 38850 KRW.
How to purchase Mezzion Pharma Co.,Ltd. stock?
You can buy 140410.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mezzion Pharma Co.,Ltd.?
The stock symbol or ticker of Mezzion Pharma Co.,Ltd. is 140410.KQ.
How many shares does Mezzion Pharma Co.,Ltd. have in circulation?
The max supply of Mezzion Pharma Co.,Ltd. shares is 8.55M.
What is Mezzion Pharma Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Mezzion Pharma Co.,Ltd. PE Ratio is now.
What was Mezzion Pharma Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Mezzion Pharma Co.,Ltd. EPS is 0 KRW over the trailing 12 months.
Mezzion Pharma Co.,Ltd. 140410.KQ included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Kosdaq MID300 Index KQ300 | 749.1 KRW 0.57 USD |
-1.05
|
— — | — — | — — | — - | — — |
Kosdaq Other Services Index KQ16 | 3507.03 KRW 2.65 USD |
-1.46
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}